Every SEC Form 3/4/5 on record for this filer (CIK 1442372) — 3 issuers, 34 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Director | 2016-05-25 → 2026-06-18 | 24 | −$7M |
| NVLN | NOVELION THERAPEUTICS INC. | Director · lapsed | 2016-12-27 → 2018-08-13 | 2 | — |
| QLTI | QLT INC/BC | Director · lapsed | 2015-07-01 → 2016-06-21 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| LGND | 2026-06-16 | Sell | 2,145 | $254.00 | $544,830 | 33,629 |
| LGND | 2026-03-23 | Sell | 1,000 | $207.87 | $207,870 | 32,793 |
| LGND | 2026-03-03 | Sell | 2,034 | $201.50 | $409,851 | 33,793 |
| LGND | 2024-03-05 | Sell | 1,893 | $74.30 | $140,650 | 28,926 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.